Ionis Pharmaceuticals (IONS)

37.63 +0.49 (1.32%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/4/21)

Latest Headlines

Lp(a) HORIZON achieves 50% enrollment in trial to assess the safety and efficacy of pelacarsen in reducing recurrent cardiovascular events August 2, 2021 9:30 AM - PR NewsWire Ionis completes enrollment in pivotal NEURO-TTRansform study of eplontersen July 29, 2021 7:05 AM - PR NewsWire Biogen (BIIB), Ionis (IONS) report positive topline clinical data on investigational Alzheimer's disease treatment at AAIC July 26, 2021 4:36 PM - StreetInsider Biogen and Ionis report positive topline clinical data on investigational Alzheimer's disease treatment at AAIC July 26, 2021 4:35 PM - PR NewsWire Ionis to hold second quarter 2021 financial results webcast July 21, 2021 7:05 AM - PR NewsWire Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: WENDER JOSEPH H July 19, 2021 8:17 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: Reikes Peter N July 19, 2021 8:17 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: PARSHALL B LYNNE July 19, 2021 8:17 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: MUTO FREDERICK T July 19, 2021 8:16 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: LOSCALZO JOSEPH July 19, 2021 8:15 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: KLEIN JOSEPH III July 19, 2021 8:14 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: HERMAN JOAN E July 19, 2021 8:14 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: Hayden Michael R July 19, 2021 8:14 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: BERTHELSEN SPENCER R July 19, 2021 8:13 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 15 Filed by: Diaz Allene M. July 19, 2021 8:13 PM - SEC Filing Ionis Pharmaceuticals (IONS) PT Lowered to $33 at Morgan Stanley July 16, 2021 4:06 AM - StreetInsider Ionis Pharmaceuticals (IONS) enters pact with Bicycle Therapeutics (BCYC) aimed at further advancing LICA technology July 13, 2021 6:59 AM - StreetInsider Ionis enters exclusive licensing agreement with Bicycle Therapeutics aimed at further advancing LICA technology July 13, 2021 6:59 AM - PR NewsWire Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: WENDER JOSEPH H July 6, 2021 5:53 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: Reikes Peter N July 6, 2021 5:53 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: PARSHALL B LYNNE July 6, 2021 5:52 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: MUTO FREDERICK T July 6, 2021 5:52 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: LOSCALZO JOSEPH July 6, 2021 5:52 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: Diaz Allene M. July 6, 2021 5:52 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: KLEIN JOSEPH III July 6, 2021 5:52 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: HERMAN JOAN E July 6, 2021 5:51 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: Hayden Michael R July 6, 2021 5:51 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jul 01 Filed by: BERTHELSEN SPENCER R July 6, 2021 5:51 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jun 23 Filed by: BERTHELSEN SPENCER R June 25, 2021 5:20 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jun 15 Filed by: MUTO FREDERICK T June 17, 2021 5:06 PM - SEC Filing Form 4 IONIS PHARMACEUTICALS For: Jun 10 Filed by: HERMAN JOAN E June 14, 2021 6:46 PM - SEC Filing Ionis' Chief Scientific Officer C. Frank Bennett, Ph.D., receives Gabbay Award in Biotechnology and Medicine June 14, 2021 4:05 PM - PR NewsWire Ionis' antisense therapies in ATTR amyloidosis to be featured at 2021 PNS Annual Meeting June 10, 2021 6:05 PM - PR NewsWire Biogen (BIIB) Says New Data at Cure SMA 2021 Highlight Long-Term Efficacy of SPINRAZA and its Commitment to Innovation in SMA Therapy June 10, 2021 7:35 AM - StreetInsider New Data at Cure SMA 2021 Highlight the Long-Term Efficacy of SPINRAZA® (nusinersen) and Biogen’s Commitment to Innovation in SMA Therapy June 10, 2021 7:30 AM - Globe NewsWire New Data at Cure SMA 2021 Highlight the Long-Term Efficacy of SPINRAZA® (nusinersen) and Biogen’s Commitment to Innovation in SMA Therapy June 10, 2021 7:30 AM - StreetInsider Form 3 IONIS PHARMACEUTICALS For: Jun 03 Filed by: Diaz Allene M. June 9, 2021 7:02 PM - SEC Filing Form 8-K IONIS PHARMACEUTICALS For: Jun 02 June 4, 2021 4:44 PM - SEC Filing Ionis Pharmaceuticals (IONS) Names Joseph Loscalzo Chairman, Allene Diaz Appointed Director June 3, 2021 6:26 AM - StreetInsider Ionis announces changes to its board of directors at annual meeting of stockholders June 2, 2021 8:00 PM - PR NewsWire Ionis to present at upcoming investor conferences May 26, 2021 7:05 AM - PR NewsWire Form DEFA14A IONIS PHARMACEUTICALS May 20, 2021 4:28 PM - SEC Filing UBS Upgrades Ionis Pharmaceuticals (IONS) to Neutral (friday) May 10, 2021 7:40 AM - StreetInsider UBS Upgrades Ionis Pharmaceuticals (IONS) to Neutral May 7, 2021 4:11 AM - StreetInsider Ionis to present at upcoming investor conferences May 6, 2021 7:05 AM - PR NewsWire Ionis Pharmaceuticals (IONS) PT Lowered to $35 at Morgan Stanley May 6, 2021 2:56 AM - StreetInsider Ionis to host 2021 virtual annual meeting of stockholders May 5, 2021 4:05 PM - PR NewsWire Ionis Pharmaceuticals (IONS) PT Lowered to $84 at Needham & Company, Following Earnings May 5, 2021 3:14 PM - StreetInsider Form 10-Q IONIS PHARMACEUTICALS For: Mar 31 May 5, 2021 2:59 PM - SEC Filing Form 8-K IONIS PHARMACEUTICALS For: May 05 May 5, 2021 11:16 AM - SEC Filing Ionis Pharmaceuticals (IONS) Misses Q1 EPS by 11c, Revenues Miss May 5, 2021 7:17 AM - StreetInsider Ionis reports first quarter 2021 financial results and recent business achievements May 5, 2021 7:00 AM - PR NewsWire Full Article List